None.
In the treatment of chronic wounds (e.g., diabetic foot ulcers) electrosurgical procedures may be used to promote healing. In particular, electrosurgical procedures may be used for debriding the wound, inducing blood flow to the wound, coagulating blood flow from the wound, removing necrotic tissue, and/or removing bacterial films which may form (the bacterial films sometimes referred to as “biofilm”). In many cases wounds are considered “dry” in the sense that there is insufficient conductive fluid present to support plasma creation for electrosurgical procedures. In such cases a conductive fluid (e.g., saline) is provided to help support plasma creation.
However, in providing a conductive fluid to a wound to help support plasma creation, the location of the wound and/or the orientation of the patient may adversely impact how the conductive fluid is distributed. For example, gravity may cause the conductive fluid to flow in such a way as to not fully “wet” one or more of the electrodes involved in the plasma creation, thus limiting or preventing plasma creation.
Any advance that better controls distribution of conductive fluid in and around the electrodes of an electrosurgical system would provide a competitive advantage.
For a detailed description of exemplary embodiments, reference will now be made to the accompanying drawings in which:
Certain terms are used throughout the following description and claims to refer to particular system components. As one skilled in the art will appreciate, companies that design and manufacture electrosurgical systems may refer to a component by different names. This document does not intend to distinguish between components that differ in name but not function.
In the following discussion and in the claims, the terms “including” and “comprising” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to . . . .” Also, the term “couple” or “couples” is intended to mean either an indirect or direct connection. Thus, if a first device couples to a second device, that connection may be through a direct connection or through an indirect electrical connection via other devices and connections.
Reference to a singular item includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said” and “the” include plural references unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement serves as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Lastly, it is to be appreciated that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
“Active electrode” shall mean an electrode of an electrosurgical wand which produces an electrically-induced tissue-altering effect when brought into contact with, or close proximity to, a tissue targeted for treatment.
“Return electrode” shall mean an electrode of an electrosurgical wand which serves to provide a current flow return path with respect to an active electrode, and/or an electrode of an electrical surgical wand which does not itself produce an electrically-induced tissue-altering effect on tissue targeted for treatment.
A fluid conduit said to be “within” an elongate housing shall include not only a separate fluid conduit that physically resides within an internal volume of the elongate housing, but also situations where the internal volume of the elongate housing is itself the fluid conduit.
“Abut” and “abutting” shall mean that two items are adjacent, but shall not be read to require that two items actually touch.
Where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein.
All existing subject matter mentioned herein (e.g., publications, patents, patent applications and hardware) is incorporated by reference herein in its entirety except insofar as the subject matter may conflict with that of the present invention (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.
Before the various embodiments are described in detail, it is to be understood that this invention is not limited to particular variations set forth herein as various changes or modifications may be made, and equivalents may be substituted, without departing from the spirit and scope of the invention. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.
Though not visible in the view of
Still referring to
In some embodiments the electrosurgical system 100 also comprises a foot pedal assembly 130. The foot pedal assembly 130 may comprise one or more pedal devices 132 and 134, a flexible multi-conductor cable 136 and a pedal connector 138. While only two pedal devices 132, 134 are shown, one or more pedal devices may be implemented. The outer surface 122 of the controller 104 may comprise a corresponding connector 140 that couples to the pedal connector 138. The foot pedal assembly 130 may be used to control various aspects of the controller 104, such as the operational mode. For example, a pedal device, such as pedal device 132, may be used for on-off control of the application of radio frequency (RF) energy to the wand 102. A second pedal device, such as pedal device 134, may be used to control and/or set the operational mode of the electrosurgical system. For example, actuation of pedal device 134 may switch between energy levels. In yet still further embodiments, the wand 102 may further comprise switches accessible on an outside portion, where the switches may control the operational modes of the controller 104.
The electrosurgical system 100 of the various embodiments may have a variety of operational modes. One such mode employs Coblation® technology. In particular, the assignee of the present disclosure is the owner of Coblation® technology. Coblation® technology involves the application of an RF energy between one or more active electrodes and one or more return electrodes of the wand 102 to develop high electric field intensities in the vicinity of the target tissue. The electric field intensities may be sufficient to vaporize an electrically conductive fluid over at least a portion of the one or more active electrodes in the region near the one or more active electrodes and the target tissue. Electrically conductive fluid may be inherently present in the body, such as blood, puss, or in some cases extracellular or intracellular fluid. In other embodiments, the electrically conductive fluid may be a liquid or gas, such as isotonic saline. In a particular embodiment of wound treatment, the electrically conductive fluid is delivered in the vicinity of the active electrode and/or to the target site by the wand 102, such as by way of the internal fluid conduit and flexible tubular member 116.
When the electrically conductive fluid is heated to the point that the atoms of the fluid vaporize faster than the atoms recondense, a gas is formed. When sufficient energy is applied to the gas, the atoms collide with each other causing a release of electrons in the process, and an ionized gas or plasma is formed (the so-called “fourth state of matter”). Stated otherwise, plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through the gas, or by directing electromagnetic waves into the gas. The methods of plasma formation give energy to free electrons in the plasma directly, electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.
As the density of the plasma becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases such that subsequently injected electrons cause impact ionization within the plasma. When the ionic particles in the plasma layer have sufficient energy (e.g., 3.5 electron-Volt (eV) to 5 eV), collisions of the ionic particles with molecules that make up the target tissue break molecular bonds of the target tissue, dissociating molecules into free radicals which then combine into gaseous or liquid species. Often, the electrons in the plasma carry the electrical current or absorb the electromagnetic waves and, therefore, are hotter than the ionic particles. Thus, the electrons, which are carried away from the target tissue toward the active or return electrodes, carry most of the plasma's heat, enabling the ionic particles to break apart the target tissue molecules in a substantially non-thermal manner.
By means of the molecular dissociation (as opposed to thermal evaporation or carbonization), the target tissue is volumetrically removed through molecular dissociation of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. The molecular dissociation completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as occurs in related art electrosurgical desiccation and vaporization. A more detailed description of the molecular dissociation can be found in commonly assigned U.S. Pat. No. 5,697,882, the complete disclosure of which is incorporated herein by reference.
In addition to the Coblation® mode, the electrosurgical system 100 of
The energy density produced by electrosurgical system 100 at the distal end 108 of the wand 102 may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and/or sharp edges on the electrode surfaces; electrode materials; applied voltage; current limiting of one or more electrodes (e.g., by placing an inductor in series with an electrode); electrical conductivity of the fluid in contact with the electrodes; density of the conductive fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Since different tissue structures have different molecular bonds, the electrosurgical system 100 may be configured to produce energy sufficient to break the molecular bonds of certain tissue but insufficient to break the molecular bonds of other tissue.
A more complete description of the various phenomena can be found in commonly assigned U.S. Pat. Nos. 6,355,032; 6,149,120 and 6,296,136, the complete disclosures of which are incorporated herein by reference.
The support member 206 is coupled to the elongate housing 106. In a particular embodiment, the elongate housing 106 and handle 110 (
An illustrative two active electrodes 202 and 204 are coupled to the support member 206. Each active electrode is a metallic structure, around which plasma is created during use in some operational modes. In some case, the wire is stainless steel, but other types of metallic wire (e.g., tungsten, molybdenum) may be equivalently used. As illustrated, each active electrode 202 and 204 is a loop of wire having a particular diameter. Smaller diameter wire for the active electrodes advantageously results in less thermal heating of the tissue, but there is a tradeoff with wire strength, as smaller wire diameters tend to break and/or bend more easily. In some embodiments, the wire diameter for each active electrode is between and including 0.008 and 0.015 inches, and in a particular case 0.010 inches. Using active electrode 202 as exemplary of both active electrodes, the illustrative active electrode 202 comprises a straight portion 212, as well as two standoff portions 214 (labeled 214A and 214B). In accordance with at least some embodiments, the length of the straight portion 212 (i.e., standoff distance) is between and including 0.16 and 0.18 inches. Moreover, standoff portions 214 define an exposed length of between and including 0.010 and 0.050 inches, and in some cases between and including 0.015 and 0.025 inches. In these embodiments the length defined by the standoff portions 214 is measured from the surface 216 of the support member 206 to the central axis of the straight portion 202. It will be understood, however, that the standoff portions 214 may extend into the support member 206, and thus will be longer than the exposed length. For the example wire diameters and lengths of this paragraph, the exposed surface area of each active electrode (i.e., that portion residing outside the non-conductive support member 206) may be between and including 0.00447 and 0.04141 square inches.
Still referring to active electrode 202 as illustrative of both active electrodes, the active electrode 202 is electrically coupled to the controller 104 (
The straight portions of the active electrodes in
In the various embodiments, the conductive fluid has conductivity above a minimum threshold. More particularly, the conductive fluid will have conductivity greater than 0.2 milli-Siemens per centimeter (mS/cm), in some cases greater than about 2 mS/cm, and in other cases greater than about 10 mS/cm. An example of the conductive fluid that may be used is isotonic saline, having conductivity of about 17 mS/cm. During wound debridement, saline may flow at the rate of between and including 30 and 70 milli-Liters per min (mL/min), but may vary depending on factors such as: the pressure at the aspiration aperture 200; the geometry, material property and configuration of the return electrode (discussed below); the geometry, material properties and configuration of the active electrodes 202 and 204; and the geometry, material properties and configuration of the support member 206.
The distal end 108 of the wand 102 further comprises a return electrode in the form of a conductive plate 210. In particular, the conductive plate 210 abuts the discharge aperture 208, and in the embodiments of
The conductive plate 210 is made of conductive material, which conductive material forms a return path for electrical current associated with energy applied to the active electrodes. In some cases the conductive plate 210 is made of stainless steel, but other types of metals (e.g., tungsten, molybdenum) may be equivalently used. The illustrative conductive plate 210 is oriented such that at least some of the conductive fluid flowing through the fluid conduit 218 contacts the conductive plate 210 before contacting an adjacent wound or contacting the active electrodes 202 and 204. For the particular embodiment of the conductive plate 210 forming at least a portion of the fluid conduit 218 through which the conductive fluid flows, the upper (in the view of
Conductive plate 210 is electrically coupled to the controller 104 (
Having the conductive plate 210 at least partially define the fluid conduit 218, and further having the conductive plate 210 oriented in such a way that conductive fluid exiting the discharge aperture 208 encounters the conductive plate 210 and aids in operation of the wand 102 for wound care in several ways. First, having the conductive plate 210 at least partially form the fluid conduit 218 increases the likelihood that the conductive fluid used to wet the electrodes makes good contact with the conductive plate 210 operated as a return electrode. Stated otherwise, regardless of the orientation of the wand 102 with respect to gravity, the conductive fluid provided to the wound treatment site has a better chance of contacting the conductive plate 210 operated as a return electrode due at least in part to the orientation of the conductive plate 210 relative to the discharge aperture 208. Second, the conductive plate 210 residing over the discharge aperture 208 helps direct the flowing conductive fluid toward the active electrodes 202 and 204.
In operation of the various embodiments, aggressive aspiration is contemplated to help remove larger pieces of tissue detached via the ablative process but not molecularly disassociated (discussed more below). In some cases, the aspiration may be created by an applied pressure between and including 100 millimeters of mercury (mmHg) and 400 mmHg below atmospheric. However, in some cases aggravation of an existing wound may occur if the aspiration aperture 200 is allowed to seal against the wound. In order to reduce the possibility of the aspiration aperture 200 sealing against the wound and/or patient, and as illustrated, in some embodiments at least a portion of the aspiration aperture is closer to the handle 110 (
L=(Wa−ID)*2.3 (1)
where ID is the internal diameter of the lumen 252. Thus, for example, a fluid conduit 270 associated with an aspiration aperture in operational relationship to a wand 102 with a single active electrode will have a shorter length than in the transition to the internal lumen than a fluid conduit 270 associated with an aspiration aperture in operational relationship to a wand 102 with three or more active electrodes.
The inventors of the present specification present the characteristic of the length L of
The various embodiments discussed to this point have had two active electrodes. However, other numbers of active electrodes may be equivalently used. For example,
As illustrated in
While illustrative wand connector 114 is shown to have the tab 1000 and male electrical pins 1002, and controller connector 120 is shown to have the slot 1100 and female electrical pins 1102, in alternative embodiments the wand connector has the female electrical pins and slot, and the controller connector 120 has the tab and male electrical pins, or other combination. In other embodiments, the arrangement of the pins within the connectors may enable only a single orientation for connection of the connectors, and thus the tab and slot arrangement may be omitted. In yet still other embodiments, other mechanical arrangements to ensure the wand connector and controller connector couple in only one orientation may be equivalently used.
ROM 1204 stores instructions executable by the processor 1200. In particular, the ROM 1204 may comprise a software program that implements the various embodiments of controlling the voltage generator 1216 (responsive to commands from the user), as well as interfacing with the user by way of the display device 124 and/or the foot pedal assembly 130 (
Voltage generator 1216 generates selectable alternating current (AC) voltages that are applied to the electrodes of the wand 102. In various embodiments, the voltage generator defines two terminals 1224 and 1226. The terminals 1224 and 1226 may couple to active electrodes and return electrodes. As an example, terminal 1224 couples to illustrative active electrodes 202 and 204, and terminal 1226 couples to the conductive plate 210 acting as return electrode. In accordance with the various embodiments, the voltage generator generates an alternating current (AC) voltage across the terminals 1224 and 1226. In at least some embodiments the voltage generator 1216 is electrically “floated” from the balance of the supply power in the controller 104, and thus the voltage on terminals 1224, 1226, when measured with respect to the earth ground or common (e.g., common 1228) within the controller 104, may or may not show a voltage difference even when the voltage generator 1216 is active.
The voltage generated and applied between the active terminal 1224 and return terminal 1226 by the voltage generator 1216 is a RF signal that, in some embodiments, has a frequency of between about 5 kilo-Hertz (kHz) and 20 Mega-Hertz (MHz), in some cases being between about 30 kHz and 2.5 MHz, often between about 100 kHz and 200 kHz. The RMS (root mean square) voltage generated by the voltage generator 816 may be in the range from about 5 Volts (V) to 1000 V, preferably being in the range from about 10 V to 500 V, often between about 100 V to 350 V depending on the active electrode size and the operating frequency. The peak-to-peak voltage generated by the voltage generator 1216 for ablation for wound treatment in some embodiments is a square wave form in the range of 10 V to 2000 V and in some cases in the range of 100 V to 1800 V and in other cases in the range of about 28 V to 1200 V, often in the range of about 100 V to 320V peak-to-peak (again, depending on the electrode size and the operating frequency).
Still referring to the voltage generator 1216, the voltage generator 1216 delivers average energy levels ranging from several milliwatts to hundreds of watts per electrode, depending on the voltage applied for the target tissue being treated, and/or the maximum allowed temperature selected for the wand 102. The voltage generator 1216 is configured to enable a user to select the voltage level according to the specific requirements of a particular procedure. A description of one suitable voltage generator 1216 can be found in commonly assigned U.S. Pat. Nos. 6,142,992 and 6,235,020, the complete disclosure of both patents are incorporated herein by reference for all purposes.
In some embodiments, the various operational modes of the voltage generator 1216 may be controlled by way of digital-to-analog converter 1206. That is, for example, the processor 1200 may control the output voltage by providing a variable voltage to the voltage generator 1216, where the voltage provided is proportional to the voltage generated by the voltage generator 1216. In other embodiments, the processor 1200 may communicate with the voltage generator by way of one or more digital output signals from the digital output 1208 device, or by way of packet based communications using the communication device 1212 (connection not specifically shown so as not to unduly complicate
While preferred embodiments of this disclosure have been shown and described, modifications thereof can be made by one skilled in the art without departing from the scope or teaching herein. The embodiments described herein are exemplary only and are not limiting. Because many varying and different embodiments may be made within the scope of the present inventive concept, including equivalent structures, materials, or methods hereafter though of, and because many modifications may be made in the embodiments herein detailed in accordance with the descriptive requirements of the law, it is to be understood that the details herein are to be interpreted as illustrative and not in a limiting sense.
Number | Name | Date | Kind |
---|---|---|---|
2050904 | Trice | Apr 1936 | A |
2056377 | Wappler | Oct 1939 | A |
3633425 | Sanford | Jan 1972 | A |
3707149 | Hao et al. | Dec 1972 | A |
3718617 | Royal | Feb 1973 | A |
3815604 | O'Malley et al. | Jun 1974 | A |
3828780 | Morrison, Jr. et al. | Aug 1974 | A |
3901242 | Storz | Aug 1975 | A |
3920021 | Hiltebrandt | Nov 1975 | A |
3939839 | Curtiss | Feb 1976 | A |
3963030 | Newton | Jun 1976 | A |
3964487 | Judson | Jun 1976 | A |
3970088 | Morrison | Jul 1976 | A |
4033351 | Hetzel | Jul 1977 | A |
4040426 | Morrison, Jr. | Aug 1977 | A |
4043342 | Morrison, Jr. | Aug 1977 | A |
4074718 | Morrison, Jr. | Feb 1978 | A |
4092986 | Schneiderman | Jun 1978 | A |
4114623 | Meinke et al. | Sep 1978 | A |
4116198 | Roos | Sep 1978 | A |
4181131 | Ogiu | Jan 1980 | A |
4184492 | Meinke et al. | Jan 1980 | A |
4202337 | Hren et al. | May 1980 | A |
4228800 | Degler, Jr. et al. | Oct 1980 | A |
4232676 | Herczog | Nov 1980 | A |
4240441 | Khalil | Dec 1980 | A |
4248231 | Herczog et al. | Feb 1981 | A |
4301801 | Schneiderman | Nov 1981 | A |
4326529 | Doss et al. | Apr 1982 | A |
4346715 | Gammell | Aug 1982 | A |
4378801 | Oosten | Apr 1983 | A |
4381007 | Doss | Apr 1983 | A |
4418692 | Guay | Dec 1983 | A |
4474179 | Koch | Oct 1984 | A |
4476862 | Pao | Oct 1984 | A |
4509532 | DeVries | Apr 1985 | A |
4520818 | Mickiewicz | Jun 1985 | A |
4532924 | Auth et al. | Aug 1985 | A |
4548207 | Reimels | Oct 1985 | A |
4567890 | Ohta et al. | Feb 1986 | A |
4572206 | Geddes et al. | Feb 1986 | A |
4580557 | Hertzmann | Apr 1986 | A |
4587975 | Salo et al. | May 1986 | A |
4590934 | Malis et al. | May 1986 | A |
4593691 | Lindstrom et al. | Jun 1986 | A |
4658817 | Hardy | Apr 1987 | A |
4660571 | Hess et al. | Apr 1987 | A |
4674499 | Pao | Jun 1987 | A |
4682596 | Bales et al. | Jul 1987 | A |
4706667 | Roos | Nov 1987 | A |
4709698 | Johnston et al. | Dec 1987 | A |
4727874 | Bowers et al. | Mar 1988 | A |
4750902 | Wuchinich et al. | Jun 1988 | A |
4765331 | Petruzzi et al. | Aug 1988 | A |
4785823 | Eggers et al. | Nov 1988 | A |
4805616 | Pao | Feb 1989 | A |
4823791 | D'Amelio et al. | Apr 1989 | A |
4832048 | Cohen | May 1989 | A |
4860752 | Turner | Aug 1989 | A |
4898169 | Norman et al. | Feb 1990 | A |
4907589 | Cosman | Mar 1990 | A |
4920978 | Colvin | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936301 | Rexroth et al. | Jun 1990 | A |
4943290 | Rexroth et al. | Jul 1990 | A |
4955377 | Lennox et al. | Sep 1990 | A |
4966597 | Cosman | Oct 1990 | A |
4967765 | Turner et al. | Nov 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
4979948 | Geddes et al. | Dec 1990 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5007908 | Rydell | Apr 1991 | A |
5009656 | Reimels | Apr 1991 | A |
5026387 | Thomas | Jun 1991 | A |
5035696 | Rydell | Jul 1991 | A |
5047026 | Rydell | Sep 1991 | A |
5047027 | Rydell | Sep 1991 | A |
5057105 | Malone et al. | Oct 1991 | A |
5057106 | Kasevich et al. | Oct 1991 | A |
5078717 | Parins et al. | Jan 1992 | A |
5080660 | Buelna | Jan 1992 | A |
5083565 | Parins et al. | Jan 1992 | A |
5084044 | Quint | Jan 1992 | A |
5085659 | Rydell | Feb 1992 | A |
5088997 | Delahuerga et al. | Feb 1992 | A |
5092339 | Geddes et al. | Mar 1992 | A |
5098431 | Rydell | Mar 1992 | A |
5099840 | Goble | Mar 1992 | A |
5102410 | Dressel | Apr 1992 | A |
5108391 | Flachenecker et al. | Apr 1992 | A |
RE33925 | Bales et al. | May 1992 | E |
5112330 | Nishigaki et al. | May 1992 | A |
5122138 | Manwaring | Jun 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5156151 | Imran | Oct 1992 | A |
5167659 | Ohtomo et al. | Dec 1992 | A |
5171311 | Rydell et al. | Dec 1992 | A |
5174304 | Latina et al. | Dec 1992 | A |
5178620 | Eggers et al. | Jan 1993 | A |
5183338 | Wickersheim et al. | Feb 1993 | A |
5190517 | Zieve et al. | Mar 1993 | A |
5192280 | Parins | Mar 1993 | A |
5195959 | Smith | Mar 1993 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5197963 | Parins | Mar 1993 | A |
5207675 | Canady | May 1993 | A |
5217457 | Delahuerga et al. | Jun 1993 | A |
5217459 | Kamerling | Jun 1993 | A |
5249585 | Turner et al. | Oct 1993 | A |
5255980 | Thomas et al. | Oct 1993 | A |
5261410 | Alfano et al. | Nov 1993 | A |
5267994 | Gentelia et al. | Dec 1993 | A |
5267997 | Farin et al. | Dec 1993 | A |
5273524 | Fox et al. | Dec 1993 | A |
5277201 | Stern | Jan 1994 | A |
5281216 | Klicek | Jan 1994 | A |
5281218 | Imran | Jan 1994 | A |
5282799 | Rydell | Feb 1994 | A |
5290282 | Casscells | Mar 1994 | A |
5300069 | Hunsberger et al. | Apr 1994 | A |
5306238 | Fleenor | Apr 1994 | A |
5312400 | Bales et al. | May 1994 | A |
5314406 | Arias et al. | May 1994 | A |
5318563 | Malis et al. | Jun 1994 | A |
5324254 | Phillips | Jun 1994 | A |
5330470 | Hagen | Jul 1994 | A |
5334140 | Philips | Aug 1994 | A |
5334183 | Wuchinich | Aug 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5336220 | Ryan et al. | Aug 1994 | A |
5336443 | Odashima | Aug 1994 | A |
5342357 | Nardella | Aug 1994 | A |
5348554 | Imran et al. | Sep 1994 | A |
5363324 | Hashimoto et al. | Nov 1994 | A |
5366443 | Eggers et al. | Nov 1994 | A |
5370675 | Edwards et al. | Dec 1994 | A |
5374261 | Yoon | Dec 1994 | A |
5375588 | Yoon | Dec 1994 | A |
5380277 | Phillips | Jan 1995 | A |
5380316 | Aita | Jan 1995 | A |
5383876 | Nardella | Jan 1995 | A |
5383917 | Desai et al. | Jan 1995 | A |
5389096 | Aita | Feb 1995 | A |
5395312 | Desai | Mar 1995 | A |
5400267 | Denen et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5417687 | Nardella et al. | May 1995 | A |
5419767 | Eggers et al. | May 1995 | A |
5423810 | Goble et al. | Jun 1995 | A |
5423882 | Jackman et al. | Jun 1995 | A |
5436566 | Thompson et al. | Jul 1995 | A |
5437662 | Nardella | Aug 1995 | A |
5438302 | Goble | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5449356 | Walbrink et al. | Sep 1995 | A |
5451224 | Goble et al. | Sep 1995 | A |
5454809 | Janssen | Oct 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5458597 | Edwards et al. | Oct 1995 | A |
5472443 | Cordis et al. | Dec 1995 | A |
5486161 | Lax et al. | Jan 1996 | A |
5496312 | Klicek | Mar 1996 | A |
5496314 | Eggers | Mar 1996 | A |
5496317 | Goble et al. | Mar 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5507743 | Edwards et al. | Apr 1996 | A |
5514130 | Baker | May 1996 | A |
5540683 | Ichikawa et al. | Jul 1996 | A |
5542915 | Edwards et al. | Aug 1996 | A |
5549598 | O'Donnell, Jr. | Aug 1996 | A |
5554152 | Aita | Sep 1996 | A |
5556397 | Long et al. | Sep 1996 | A |
5562703 | Desai | Oct 1996 | A |
5569242 | Lax et al. | Oct 1996 | A |
5571100 | Goble et al. | Nov 1996 | A |
5573533 | Strul | Nov 1996 | A |
5584872 | LaFontaine et al. | Dec 1996 | A |
5588960 | Edwards et al. | Dec 1996 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5633578 | Eggers et al. | May 1997 | A |
5634921 | Hood et al. | Jun 1997 | A |
5643304 | Schechter et al. | Jul 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5658278 | Imran et al. | Aug 1997 | A |
5660567 | Nierlich et al. | Aug 1997 | A |
5662680 | Desai | Sep 1997 | A |
5676693 | LaFontaine et al. | Oct 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5697281 | Eggers et al. | Dec 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5697927 | Imran et al. | Dec 1997 | A |
5700262 | Acosta et al. | Dec 1997 | A |
5715817 | Stevens-Wright et al. | Feb 1998 | A |
5722975 | Edwards et al. | Mar 1998 | A |
5725524 | Mulier et al. | Mar 1998 | A |
5749869 | Lindenmeier et al. | May 1998 | A |
5749871 | Hood et al. | May 1998 | A |
5749914 | Janssen | May 1998 | A |
5755753 | Knowlton | May 1998 | A |
5766153 | Eggers et al. | Jun 1998 | A |
5769847 | Panescu et al. | Jun 1998 | A |
5785705 | Baker | Jul 1998 | A |
5786578 | Christy et al. | Jul 1998 | A |
5800429 | Edwards | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5810802 | Panescu et al. | Sep 1998 | A |
5810809 | Rydell | Sep 1998 | A |
5836875 | Webster, Jr. | Nov 1998 | A |
5843019 | Eggers et al. | Dec 1998 | A |
5860951 | Eggers | Jan 1999 | A |
5860974 | Abele | Jan 1999 | A |
5860975 | Goble et al. | Jan 1999 | A |
5871469 | Eggers et al. | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5873877 | McGaffigan | Feb 1999 | A |
5885277 | Korth | Mar 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5891134 | Goble et al. | Apr 1999 | A |
5897553 | Mulier | Apr 1999 | A |
5902272 | Eggers et al. | May 1999 | A |
5944715 | Goble et al. | Aug 1999 | A |
5954716 | Sharkey et al. | Sep 1999 | A |
5964786 | Ochs et al. | Oct 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6013076 | Goble et al. | Jan 2000 | A |
6015406 | Goble et al. | Jan 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6027501 | Goble et al. | Feb 2000 | A |
6039734 | Goble et al. | Mar 2000 | A |
6047700 | Eggers et al. | Apr 2000 | A |
6056746 | Goble et al. | May 2000 | A |
6063079 | Hovda et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6068628 | Fanton et al. | May 2000 | A |
6074386 | Goble et al. | Jun 2000 | A |
6090106 | Goble et al. | Jul 2000 | A |
6093186 | Goble et al. | Jul 2000 | A |
6102046 | Weinstein et al. | Aug 2000 | A |
6105581 | Eggers et al. | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6117109 | Eggers et al. | Sep 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6159194 | Eggers et al. | Dec 2000 | A |
6159208 | Hovda et al. | Dec 2000 | A |
6162217 | Kannenberg et al. | Dec 2000 | A |
6168593 | Sharkey et al. | Jan 2001 | B1 |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6179836 | Eggers et al. | Jan 2001 | B1 |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6190381 | Olsen et al. | Feb 2001 | B1 |
6197021 | Panescu et al. | Mar 2001 | B1 |
6203542 | Ellsberry et al. | Mar 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6210405 | Goble et al. | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6228078 | Eggers | May 2001 | B1 |
6228081 | Goble | May 2001 | B1 |
6234178 | Goble et al. | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6237604 | Burnside et al. | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6238393 | Mulier et al. | May 2001 | B1 |
6254600 | Willink et al. | Jul 2001 | B1 |
6261286 | Goble et al. | Jul 2001 | B1 |
6261311 | Sharkey et al. | Jul 2001 | B1 |
6264652 | Eggers et al. | Jul 2001 | B1 |
6270460 | McCartan et al. | Aug 2001 | B1 |
6277112 | Underwood et al. | Aug 2001 | B1 |
6280441 | Ryan | Aug 2001 | B1 |
6283961 | Underwood et al. | Sep 2001 | B1 |
6293942 | Goble et al. | Sep 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6306134 | Goble et al. | Oct 2001 | B1 |
6308089 | von der Rur et al. | Oct 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6312408 | Eggers et al. | Nov 2001 | B1 |
6322549 | Eggers et al. | Nov 2001 | B1 |
6346104 | Daly et al. | Feb 2002 | B2 |
6346107 | Cucin | Feb 2002 | B1 |
6355032 | Hovda et al. | Mar 2002 | B1 |
6363937 | Hovda et al. | Apr 2002 | B1 |
6364877 | Goble et al. | Apr 2002 | B1 |
6379351 | Thapliyal et al. | Apr 2002 | B1 |
6391025 | Weinstein et al. | May 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
6416507 | Eggers et al. | Jul 2002 | B1 |
6416508 | Eggers et al. | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6432103 | Ellsberry et al. | Aug 2002 | B1 |
6440129 | Simpson | Aug 2002 | B1 |
6468274 | Alleyne et al. | Oct 2002 | B1 |
6468275 | Wampler et al. | Oct 2002 | B1 |
6482201 | Olsen et al. | Nov 2002 | B1 |
6514250 | Jahns et al. | Feb 2003 | B1 |
6517498 | Burbank et al. | Feb 2003 | B1 |
6530922 | Cosman | Mar 2003 | B2 |
6558382 | Jahns et al. | May 2003 | B2 |
6565560 | Goble et al. | May 2003 | B1 |
6578579 | Burnside | Jun 2003 | B2 |
6589237 | Woloszko et al. | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6620156 | Garito et al. | Sep 2003 | B1 |
6632193 | Davison et al. | Oct 2003 | B1 |
6632220 | Eggers et al. | Oct 2003 | B1 |
6635034 | Cosmescu | Oct 2003 | B1 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6730080 | Harano et al. | May 2004 | B2 |
6749604 | Eggers et al. | Jun 2004 | B1 |
6749608 | Garito et al. | Jun 2004 | B2 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6780178 | Palanker et al. | Aug 2004 | B2 |
6780180 | Goble et al. | Aug 2004 | B1 |
6802842 | Ellman et al. | Oct 2004 | B2 |
6837887 | Woloszko et al. | Jan 2005 | B2 |
6837888 | Ciarrocca et al. | Jan 2005 | B2 |
6866671 | Tierney et al. | Mar 2005 | B2 |
6878149 | Gatto | Apr 2005 | B2 |
6890307 | Kokate et al. | May 2005 | B2 |
6892086 | Russell | May 2005 | B2 |
6911027 | Edwards et al. | Jun 2005 | B1 |
6920883 | Bessette et al. | Jul 2005 | B2 |
6929640 | Underwood et al. | Aug 2005 | B1 |
6949096 | Davison et al. | Sep 2005 | B2 |
6960204 | Eggers et al. | Nov 2005 | B2 |
6974453 | Woloszko et al. | Dec 2005 | B2 |
6979328 | Baerveldt et al. | Dec 2005 | B2 |
6979601 | Marr et al. | Dec 2005 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6986770 | Hood | Jan 2006 | B2 |
6991631 | Woloszko et al. | Jan 2006 | B2 |
7001382 | Gallo | Feb 2006 | B2 |
7004941 | Tvinnereim et al. | Feb 2006 | B2 |
7010353 | Gan et al. | Mar 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7070596 | Woloszko et al. | Jul 2006 | B1 |
7090672 | Underwood et al. | Aug 2006 | B2 |
7094215 | Davison et al. | Aug 2006 | B2 |
7094231 | Ellman et al. | Aug 2006 | B1 |
7104986 | Hovda et al. | Sep 2006 | B2 |
7115139 | McClurken et al. | Oct 2006 | B2 |
7131969 | Hovda et al. | Nov 2006 | B1 |
7169143 | Eggers et al. | Jan 2007 | B2 |
7179255 | Lettice et al. | Feb 2007 | B2 |
7186234 | Dahla et al. | Mar 2007 | B2 |
7192428 | Eggers et al. | Mar 2007 | B2 |
7201750 | Eggers et al. | Apr 2007 | B1 |
7217268 | Eggers et al. | May 2007 | B2 |
7241293 | Davison | Jul 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7270658 | Woloszko et al. | Sep 2007 | B2 |
7270659 | Hovda et al. | Sep 2007 | B2 |
7270661 | Dahla et al. | Sep 2007 | B2 |
7276063 | Davison et al. | Oct 2007 | B2 |
7278994 | Goble | Oct 2007 | B2 |
7282048 | Goble et al. | Oct 2007 | B2 |
7297143 | Woloszko et al. | Nov 2007 | B2 |
7297145 | Ormsby et al. | Nov 2007 | B2 |
7318823 | Sharps et al. | Jan 2008 | B2 |
7331956 | Hovda et al. | Feb 2008 | B2 |
7335199 | Goble et al. | Feb 2008 | B2 |
RE40156 | Sharps et al. | Mar 2008 | E |
7344532 | Goble et al. | Mar 2008 | B2 |
7357798 | Sharps et al. | Apr 2008 | B2 |
7387625 | Hovda et al. | Jun 2008 | B2 |
7419488 | Ciarrocca et al. | Sep 2008 | B2 |
7429260 | Underwood et al. | Sep 2008 | B2 |
7429262 | Woloszko et al. | Sep 2008 | B2 |
7435247 | Woloszko et al. | Oct 2008 | B2 |
7442191 | Hovda et al. | Oct 2008 | B2 |
7445618 | Eggers et al. | Nov 2008 | B2 |
7449021 | Underwood et al. | Nov 2008 | B2 |
7462178 | Woloszko et al. | Dec 2008 | B2 |
7468059 | Eggers et al. | Dec 2008 | B2 |
7491200 | Underwood et al. | Feb 2009 | B2 |
7507236 | Eggers et al. | Mar 2009 | B2 |
7572251 | Davison et al. | Aug 2009 | B1 |
7632267 | Dahla | Dec 2009 | B2 |
7678069 | Baker et al. | Mar 2010 | B1 |
7691101 | Davison et al. | Apr 2010 | B2 |
7704249 | Woloszko et al. | Apr 2010 | B2 |
7708733 | Sanders et al. | May 2010 | B2 |
20020029036 | Goble et al. | Mar 2002 | A1 |
20020042612 | Hood et al. | Apr 2002 | A1 |
20020151882 | Marko et al. | Oct 2002 | A1 |
20020183739 | Long | Dec 2002 | A1 |
20030013986 | Saadat | Jan 2003 | A1 |
20030014045 | Russell | Jan 2003 | A1 |
20030014047 | Woloszko et al. | Jan 2003 | A1 |
20030088245 | Woloszko et al. | May 2003 | A1 |
20030130655 | Woloszko et al. | Jul 2003 | A1 |
20030158545 | Hovda et al. | Aug 2003 | A1 |
20030171743 | Tasto et al. | Sep 2003 | A1 |
20030181903 | Hood et al. | Sep 2003 | A1 |
20030208196 | Stone | Nov 2003 | A1 |
20030212396 | Eggers et al. | Nov 2003 | A1 |
20030216725 | Woloszko et al. | Nov 2003 | A1 |
20030216732 | Truckai et al. | Nov 2003 | A1 |
20040030330 | Brassell et al. | Feb 2004 | A1 |
20040116922 | Hovda et al. | Jun 2004 | A1 |
20040127893 | Hovda | Jul 2004 | A1 |
20040230190 | Dahla et al. | Nov 2004 | A1 |
20050004634 | Hovda et al. | Jan 2005 | A1 |
20050033278 | McClurken et al. | Feb 2005 | A1 |
20050261754 | Woloszko et al. | Nov 2005 | A1 |
20050273091 | Booth et al. | Dec 2005 | A1 |
20050288665 | Woloszko et al. | Dec 2005 | A1 |
20060036237 | Davison et al. | Feb 2006 | A1 |
20060095031 | Ormsby | May 2006 | A1 |
20060178670 | Woloszko et al. | Aug 2006 | A1 |
20060189971 | Eggers et al. | Aug 2006 | A1 |
20060253117 | Hovda et al. | Nov 2006 | A1 |
20060259025 | Dahla | Nov 2006 | A1 |
20070106288 | Woloszko et al. | May 2007 | A1 |
20070149966 | Dahla et al. | Jun 2007 | A1 |
20070161981 | Sanders et al. | Jul 2007 | A1 |
20070208334 | Woloszko et al. | Sep 2007 | A1 |
20070208335 | Woloszko et al. | Sep 2007 | A1 |
20070282323 | Woloszko et al. | Dec 2007 | A1 |
20080004621 | Dahla et al. | Jan 2008 | A1 |
20080077128 | Woloszko et al. | Mar 2008 | A1 |
20080154255 | Panos et al. | Jun 2008 | A1 |
20080167645 | Woloszko | Jul 2008 | A1 |
20080234671 | Marion | Sep 2008 | A1 |
20080243116 | Anderson | Oct 2008 | A1 |
20080300590 | Horne et al. | Dec 2008 | A1 |
20090209956 | Marion | Aug 2009 | A1 |
20100152726 | Cadouri et al. | Jun 2010 | A1 |
20100228246 | Marion | Sep 2010 | A1 |
Number | Date | Country |
---|---|---|
3119735 | Jan 1983 | DE |
3930451 | Mar 1991 | DE |
423757 | Mar 1996 | EP |
0703461 | Mar 1996 | EP |
0740926 | Nov 1996 | EP |
0754437 | Jan 1997 | EP |
0694290 | Nov 2000 | EP |
1334699 | Aug 2003 | EP |
1428480 | Jun 2004 | EP |
1707147 | Oct 2006 | EP |
2313949 | Jan 1977 | FR |
467502 | Jun 1937 | GB |
2160102 | Dec 1985 | GB |
2299216 | Sep 1996 | GB |
2 308 979 | Jul 1997 | GB |
2 308 980 | Jul 1997 | GB |
2 308 981 | Jul 1997 | GB |
2 327 350 | Jan 1999 | GB |
2 327 351 | Jan 1999 | GB |
2 327 352 | Jan 1999 | GB |
2333455 | Jul 1999 | GB |
2406793 | Apr 2005 | GB |
57-57802 | Apr 1982 | JP |
57-117843 | Jul 1982 | JP |
9003152 | Apr 1990 | WO |
9007303 | Jul 1990 | WO |
9221278 | Dec 1992 | WO |
9313816 | Jul 1993 | WO |
9320747 | Oct 1993 | WO |
9404220 | Mar 1994 | WO |
9408654 | Apr 1994 | WO |
9410921 | May 1994 | WO |
9426228 | Nov 1994 | WO |
9534259 | Dec 1995 | WO |
9600040 | Jan 1996 | WO |
9600042 | Jan 1996 | WO |
9639086 | Dec 1996 | WO |
9700646 | Jan 1997 | WO |
9700647 | Jan 1997 | WO |
9718768 | May 1997 | WO |
9724073 | Jul 1997 | WO |
9724074 | Jul 1997 | WO |
9724993 | Jul 1997 | WO |
9724994 | Jul 1997 | WO |
9743971 | Nov 1997 | WO |
9748345 | Dec 1997 | WO |
9748346 | Dec 1997 | WO |
9807468 | Feb 1998 | WO |
9826724 | Jun 1998 | WO |
9827879 | Jul 1998 | WO |
9827880 | Jul 1998 | WO |
9920213 | Apr 1999 | WO |
9951155 | Oct 1999 | WO |
9951158 | Oct 1999 | WO |
9956648 | Nov 1999 | WO |
0000098 | Jan 2000 | WO |
0009053 | Feb 2000 | WO |
0124720 | Apr 2001 | WO |
0187154 | May 2001 | WO |
0202255 | Jan 2002 | WO |
0236028 | May 2002 | WO |
03024305 | Mar 2003 | WO |
03092477 | Nov 2003 | WO |
2004026150 | Apr 2004 | WO |
2004071278 | Aug 2004 | WO |
2005125287 | Dec 2005 | WO |
2007006000 | Jan 2007 | WO |
2007056729 | May 2007 | WO |
Entry |
---|
Barry et al., “The Effect of Radiofrequency-generated Thermal Energy on the Mechanical and Histologic Characteristics of the Arterial Wall in Vivo: Implications of Radiofrequency Angioplasty” American Heart Journal vol. 117, pp. 332-341, 1982. |
BiLAP Generator Settings, Jun. 1991. |
BiLAP IFU 910026-001 Rev A for BiLAP Model 3525, J-Hook, 4 pgs, May 20, 1991. |
BiLAP IFU 910033-002 Rev A for BiLAP Model 3527, L-Hook; BiLAP Model 3525, J-Hook; BiLAP Model 3529, High Angle, 2 pgs, Nov. 30, 1993. |
Codman & Shurtleff, Inc. “The Malis Bipolar Coagulating and Bipolar Cutting System CMC-II” brochure, early, 2 pgs, 1991. |
Codman & Shurtleff, Inc. “The Malis Bipolar Electrosurgical System CMC-III Instruction Manual”, 15 pgs, Jul. 1991. |
Cook et al., “Therapeutic Medical Devices: Application and Design” , Prentice Hall, Inc., 3pgs, 1982. |
Dennis et al. “Evolution of Electrofulguration in Control of Bleeding of Experimental Gastric Ulcers,” Digestive Diseases and Sciences, vol. 24, No. 11, 845-848, Nov. 1979. |
Dobbie, A.K., “The Electrical Aspects of Surgical Diathermy, Bio Medical Engineering” Bio-Medical Engineering vol. 4, pp. 206-216, May 1969. |
Elsasser, V.E. et al., “An Instrument for Transurethral Resection without Leakage of Current” Acta Medicotechnica vol. 24, No. 4, pp. 129-134, 1976. |
Geddes, “Medical Device Accidents: With Illustrative Cases” CRC Press, 3 pgs, 1998. |
Honig, W., “The Mechanism of Cutting in Electrosurgery” IEEE pp. 58-65 1975. |
Kramolowsky et al. “The Urological App of Electorsurgery” J. of Urology vol. 146, pp. 669-674, 1991. |
Kramolowsky et al. “Use of 5F Bipolar Electrosurgical Probe in Endoscopic Urological Procedures” J. of Urology vol. 143, pp. 275-277, 1990. |
Lee, B et al. “Thermal Compression and Molding of Artherosclerotic Vascular Tissue with Use” JACC vol. 13(5), pp. 1167-1171, 1989. |
Letter from Department of Health to Jerry Malis dated Jan. 24, 1991, 3 pgs. |
Letter from Department of Health to Jerry Malis dated Jul. 25, 1985, 1 pg. |
Letter from Jerry Malis to FDA dated Jul. 25, 1985, 2 pgs. |
Lu, et al., “Electrical Thermal Angioplasty: Catheter Design Features, in Vitro Tissue Ablation Studies and in Vitro Experimental Findings,” Am J. Cardiol vol. 60, pp. 1117-1122, Nov. 1, 1987. |
Malis, L., “Electrosurgery, Technical Note,” J. Neursurg., vol. 85, pp. 970-975, Nov. 1996. |
Malis, L., “Excerpted from a seminar by Leonard I. Malis, M.D. at the 1995 American Association of Neurological Surgeons Meeting,” 1pg, 1995. |
Malis, L., “Instrumentation for Microvascular Neurosurgery” Cerebrovascular Surgery, vol. 1, pp. 245-260, 1985. |
Malis, L., “New Trends in Microsurgery and Applied Technology,” Advanced Technology in Neurosurgery, pp. 1-16, 1988. |
Malis, L., “The Value of Irrigation During Bipolar Coagulation” See ARTC 21602, 1 pg, Apr. 9, 1993. |
Nardella, P.C., SPIE 1068: pp. 42-49, Radio Frequency Energy and Impedance Feedback, 1989. |
O'Malley, Schaum's Outline of Theory and Problems of Basic Circuit Analysis, McGraw-Hill, 2nd Ed., pp. 3-5, 1992. |
Olsen MD, Bipolar Laparoscopic Cholecstectomy Lecture (marked confidential), 12 pgs, Oct. 7, 1991. |
Pearce, John A. “Electrosurgery”, pp. 17, 69-75, 87, John Wiley & Sons, New York, 1986. |
Pearce, John A., “Electrosurgery”, Handbook of Biomedical Engineering, chapter 3, Academic Press Inc., N.Y., pp. 98-113, 1988. |
Piercey et al., “Electrosurgical Treatment of Experimental Bleeding Canine Gastric Ulcers” Gastroenterology vol. 74(3), pp. 527-534, 1978. |
Protell et al., “Computer-Assisted Electrocoagulation: Bipolar v. Monopolar in the Treatment of Experimental Canine Gastric Ulcer Bleeding,” Gastroenterology vol. 80, No. 3, pp. 451-455, 1981. |
Ramsey et al., “A Comparison of Bipolar and Monopolar Diathermy Probes in Experimental Animals”, Urological Research vol. 13, pp. 99-102, 1985. |
Selikowitz et al., “Electric Current and Voltage Recordings on the Myocardium During Electrosurgical Procedures in Canines,” Surgery, Gynecology & Obstetrics, vol. 164, pp. 219-224, Mar. 1987. |
Shuman, “Bipolar Versus Monopolar Electrosurgery: Clinical Applications,” Dentistry Today, vol. 20, No. 12, 7 pgs, Dec. 2001. |
Slager et al. “Spark Erosion of Arteriosclerotic Plaques” Z. Kardiol. 76:Suppl. 6, pp. 67-71, 1987. |
Slager et al. “Vaporization of Atherosclerotice Plaques by Spark Erosion” JACC 5(6): pp. 1382-1386, Jun. 1985. |
Stoffels, E. et al., “Investigation on the Interaction Plasma-Bone Tissue”, E-MRS Spring Meeting, 1 pg, Jun. 18-21, 2002. |
Stoffels, E. et al., “Biomedical Applications of Plasmas”, Tutorial presented prior to the 55th Gaseous Electronics Conference in Minneapolis, MN, 41 pgs Oct. 14, 2002. |
Stoffels, E. et al., “Plasma Interactions with Living Cells”, Eindhoven University of Technology, 1 pg, 2002. |
Stoffels, E. et al., “Superficial Treatment of Mammalian Cells using Plasma Needle”, J. Phys. D: Appl. Phys. 26, pp. 2908-2913, Nov. 19, 2003. |
Stoffels, E. et al., “Plasma Needle”, Eindhoven University of Technology, 1 pg, Nov. 28, 2003. |
Stoffels, E. et al., “Plasma Physicists Move into Medicine”, Physicsweb, 1 pg, Nov. 2003. |
Stoffels, E. et al., “Plasma Treated Tissue Engineered Skin to Study Skin Damage”, Biomechanics and Tissue Engineering, Materials Technology, 1 pg, 2003. |
Stoffels, E. et al., “Plasma Treatment of Dental Cavities: A Feasibility Study”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1540-1542, Aug. 2004. |
Stoffels, E. et al., “The Effects of UV Irradiation and Gas Plasma Treatment on Living Mammalian Cells and Bacteria: A Comparative Approach”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1544-1550, Aug. 2004. |
Stoffels, E. et al., “Electrical and Optical Characterization of the Plasma Needle”, New Journal of Physics 6, pp. 1-14, Oct. 28, 2004. |
Stoffels, E. et al., “Where Plasma Meets Plasma”, Eindhoven University of Technology, 23 pgs, 2004. |
Stoffels, E. et al., “Gas Plasma effects on Living Cells”, Physica Scripta, T107, pp. 79-82, 2004. |
Stoffels, E. et al., “Plasma Treatment of Mammalian Vascular Cells: A Quantitative Description”, IEEE Transaction on Plasma Science, vol. 33, No. 2, pp. 771-775, Apr. 2005. |
Stoffels, E. et al., “Deactivation of Escherichia Coli by the Plasma Needle”, J. Phys. D: Appl. Phys. 38, pp. 1716-1721, May 20, 2005. |
Stoffels, E. et al., “Development of a Gas Plasma Catheter for Gas Plasma Surgery”, XXVIIth ICPIG, Endoven University of Technology, pp. 18-22, Jul. 2005. |
Stoffels, E. et al., “Development of a Smart Positioning Sensor for the Plasma Needle”, Plasma Sources Sci. Technol. 15, pp. 582-589, Jun. 27, 2006. |
Stoffels, E. et al., Killing of S. Mutans Bacteria Using a Plasma Needle at Atmospheric Pressure, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1317-1324, Aug. 2006. |
Stoffels, E. et al., “Plasma-Needle Treatment of Substrates with Respect to Wettability and Growth of Excherichia Coli and Streptococcus mutans”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1325-1330, Aug. 2006. |
Stoffels, E. et al., “Reattachment and Apoptosis after Plasma-Needle Treatment of Cultured Cells”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1331-1336, Aug. 2006. |
Stoffels, E. et al., “UV Excimer Lamp Irradiation of Fibroblasts: The Influence on Antioxidant Homostasis”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1359-1364, Aug. 2006. |
Stoffels, E. et al., “Plasma Needle for in Vivo Medical Treatment: Recent Developments and Perspectives”, Plasma Sources Sci. Technol. 15, pp. S169-S180, Nov. 6, 2006. |
Swain, C.P., et al., “Which Electrode, A Comparison of four endoscopic methods of electrocoagulation in experimental bleeding ulcers” Gut vol. 25, pp. 1424-1431, 1987. |
Tucker, R. et al., Abstract P14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”, Nov. 1989. |
Tucker, R. et al. “A Comparison of Urologic Application of Bipolar Versus Monopolar Five French Electrosurgical Probes” J. of Urology vol. 141, pp. 662-665, 1989. |
Tucker, R. et al. “In vivo effect of 5 French Bipolar and Monopolar Electrosurgical Probes on the Porcine Bladder” Urological Research vol. 18, pp. 291-294, 1990. |
Tucker, R. et al., “Demodulated Low Frequency Currents from Electrosurgical Procedures,” Surgery, Gynecology and Obstetrics, 159:39-43, 1984. |
Tucker et al. “The interaction between electrosurgical generators, endoscopic electrodes, and tissue,” Gastrointestinal Endoscopy, vol. 38, No. 2, pp. 118-122, 1992. |
Valley Forge Scientific Corp., “Summary of Safety and Effective Information from 510K”, 2pgs, 1991. |
Valley Forge's New Products, CLINICA, 475, 5, Nov. 6, 1991. |
Valleylab SSE2L Instruction Manual, 11 pgs, Jan. 6, 1983. |
Valleylab, Inc. “Valleylab Part No. 945 100 102 A” Surgistat Service Manual, pp. 1-46, Jul. 1988. |
Wattiez, Arnaud et al., “Electrosurgery in Operative Endoscopy,” Electrosurgical Effects, Blackwell Science, pp. 85-93, 1995. |
Wyeth, “Electrosurgical Unit” pp. 1181-1202, 2000. |
Buchelt, et al. “Excimer Laser Ablation of Fibrocartilage: An in Vitro and in Vivo Study”, Lasers in Surgery and Medicine, vol. 11, pp. 271-279, 1991. |
Costello et al., “Nd: YAG Laser Ablation of the Prostate as a Treatment for Benign Prostatic Hypertrophy”, Lasers in Surgery and Medicine, vol. 12, pp. 121-124, 1992. |
Rand et al., “Effect of Elecctrocautery on Fresh Human Articular Cartilage”, J. Arthro. Surg., vol. 1, pp. 242-246, 1985. |
European Examination Report for EP 02773432 4 pgs, Sep. 22, 2009. |
European Examination Report for EP 05024974 4 pgs, Dec. 5, 2008. |
European Examination Report for EP 04708664 7pgs, Sep. 7, 2009. |
European Examination Report for EP 02749601.7 4pgs, Dec. 2, 2009. |
European Examination Report 2 for EP 04708664 5pgs, May 3, 2010. |
European Search Report for EP 02773432 3pgs, Dec. 19, 2008. |
European Search Report for EP 04708664.0 5pgs, Apr. 6, 2009. |
European Search Report for EP 98953859, 2 pgs, Jul. 2, 2001. |
Suppl European Search Report for EP 98953859, 3 pgs, Oct. 18, 2001. |
Extended European Search Report for EP09152846, 8pgs, Jan. 5, 2010. |
European Search Report for EP 99945039.8, 3 pgs, Oct. 1, 2001. |
European Search Report for EP 09152850, 2 pgs, Dec. 29, 2009. |
PCT International Preliminary Examination Report for PCT/US02/19261, 3pgs, Mar. 25, 2003. |
PCT International Search Report for PCT/US02/19261, 1 pg, Mailed Sep. 18, 2002. |
PCT International Search Report for PCT/US02/29476, 1 pg, Mailed May 24, 2004. |
PCT International Search Report for PCT/US03/13686, 1 pg, Mailed Nov. 25, 2003. |
PCT International Search Report for PCT/US04/03614, 1 pg, Mailed Sep. 14, 2004. |
PCT International Search Report for PCT/US98/22323, 1 pg, Mailed Mar. 3, 1999. |
PCT International Search Report for PCT/US99/14685, 1 pg, Mailed Oct. 21, 1999. |
PCT International Search Report for PCT/US99/18289, 1 pg, Mailed Dec. 7, 1999. |
PCT Notification of International Preliminary Examination Report for PCT/US98/22323, 5 pgs, Mailed Nov. 28, 2000. |
PCT Notification of International Preliminary Examination Report for PCT/US99/14685, 4 pgs, Mailed Feb. 20, 2001. |
PCT Notification of International Preliminary Examination Report for PCT/US99/18289, 4 pgs, Mailed Jul. 7, 2000. |
PCT Notification of International Search Report and Written Opinion for PCT/US06/26321, 8pgs, Mailed Apr. 25, 2007. |
PCT Notification of the International Search Report and Written Opinion for PCT/US06/60618, 7pgs, Mailed Oct. 5, 2007. |
PCT Notification of the International Search Report and Written Opinion for PCT/US07/69856, 7pgs, Mailed Jun. 5, 2008. |
PCT Written Opinion of the International Searching Authority for PCT/US04/03614, 4 pgs, Mailed Sep. 14, 2004. |
UK Search Report for GB0800129.9 2pgs, May 8, 2008. |
UK Search Report for GB0805062.7 1 pg, Jul. 16, 2008. |
UK Search Report for GB0900604.0 4 pgs, May 15, 2009. |
Slager et al., “Electrical nerve and Muscle Stimulation by Radio Frequency Surgery: Role of Direct Current Loops Around the Active Electrode”, IEEE Transactions on Biomedical engineering, vol. 40, No. 2, pp. 182-187, Feb. 1993. |
Number | Date | Country | |
---|---|---|---|
20120095454 A1 | Apr 2012 | US |